Presentation by Sara Carillo, NIBRT: Characterizing AAV Quality Attributes Using Mass Spectrometry
Presentation by Sara Carillo, NIBRT: Characterizing AAV Quality Attributes Using Mass Spectrometry
Loading view.
Presentation by Bingchuan Wei, Genentech: Unveiling Structural-Function Relationship through Hydrogen Deuterium Exchange Coupled with Mass Spectrometry (HDX-MS)
Presentation by Bingchuan Wei, Genentech: Unveiling Structural-Function Relationship through Hydrogen Deuterium Exchange Coupled with Mass Spectrometry (HDX-MS)
Presentation by Rachel Shi, Genentech: Innovating Mass Spectrometry Approaches for Characterizing Emerging Modality Therapeutics
Presentation by Rachel Shi, Genentech: Innovating Mass Spectrometry Approaches for Characterizing Emerging Modality Therapeutics
Presentation by Ben Niu, BMS: High-Throughput and Automation in Novel Modalities (bsAbs, ADCs) Characterizations and Beyond
Presentation by Ben Niu, BMS: High-Throughput and Automation in Novel Modalities (bsAbs, ADCs) Characterizations and Beyond
Presentation by Serena Wu, Regeneron: Development of LCMS MAM for Protein and Oligonucleotide Therapies
Presentation by Serena Wu, Regeneron: Development of LCMS MAM for Protein and Oligonucleotide Therapies
Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug Development
Presentation by Aaron Bailey, AbCellera: Leveraging the Versatility of Size Exclusion Coupled to Mass Spectrometry (SEC-MS) to Accelerate Antibody Drug…
Presentation by Chris Chumsae, BMS: Mass Spec Allows Us to ‘See’ Molecules and Solve Mysteries
Presentation by Chris Chumsae, BMS: Mass Spec Allows Us to ‘See’ Molecules and Solve Mysteries
Presentation by Anita Liu, Merck: Use of MAM for In-Process Monitoring and Quality Control of Complex Biologics
Presentation by Anita Liu, Merck: Use of MAM for In-Process Monitoring and Quality Control of Complex Biologics